WASHINGTON, D.C. – Congressman Brian Fitzpatrick (PA-1) is stepping up the fight against Alzheimer’s with the introduction of the bipartisan Global Alzheimer’s Initiative Now (GAIN) Act, alongside Representatives Ami Bera, M.D. (D-CA-06) and Young Kim (R-CA-40)—mobilizing U.S. leadership on the world stage to confront one of the most urgent and devastating diseases of our time.
The GAIN Act formally authorizes U.S. participation in the Davos Alzheimer’s Collaborative (DAC)—a groundbreaking global public–private–patient partnership advancing Alzheimer’s and dementia research, early detection, treatment, and care. With over 150 million people projected to be affected by dementia worldwide by 2050, this legislation positions the United States to lead a coordinated, global response.
“We can’t afford to stand still in the fight against Alzheimer’s. Our GAIN Act is a critical initiative to move us forward—strengthening America’s leadership, accelerating global research, and supporting smarter, earlier interventions. By backing innovative treatments and real-world solutions, we can bring hope to families, relief to caregivers, and a future where Alzheimer’s is no longer a life sentence,” said Representative Fitzpatrick.
“Alzheimer’s disease is a global challenge that demands a united global response,” said Representative Ami Bera, M.D. “The GAIN Act empowers the United States to lead in building global partnerships that accelerate research, improve care and support families both here at home and around the world. With formal authorization, we can help drive innovation and advancements in the fight against Alzheimer’s.”
“Alzheimer’s disease is the third leading cause of death in older adults in Orange County and seventh leading cause of death worldwide. With more resources dedicated to tackling this global challenge, we can save lives,” said Representative Kim. “The GAIN Act ensures the United States leads the global effort to combat Alzheimer’s disease and other forms of dementia head-on.”
"I commend Congressman Ami Bera and Representatives Brian Fitzpatrick and Young Kim for their leadership in introducing the Global Alzheimer's Initiative Now (GAIN) Act,” said Chairman of UsAgainstAlzheimer's and Founder of the Global CEO Initiative on Alzheimer's Disease George Vradenburg. “This legislation recognizes the urgent need for a global response to Alzheimer's that brings together governments and the private sector to advance prevention, diagnosis and treatment of Alzheimer's. As in other areas of global health, U.S. leadership will prove critical to the global fight against Alzheimer's, and this legislation paves the way for mobilizing the resources and facilitating the multi-sector and international cooperation that will be needed to turn the tide on Alzheimer's over the coming decades."
Alzheimer’s and other forms of dementia currently affect nearly 60 million people worldwide and cost the global economy more than $1.3 trillion annually—a figure projected to double every decade. By formally joining DAC, the United States will help drive inclusive, evidence-based solutions to the rising global dementia crisis. DAC aims to raise and deploy $700 million over six years and currently supports 19 health systems in 12 countries, including sites across the United States.
Fitzpatrick’s GAIN Act reaffirms America’s role as a global health leader and deepens our commitment to unlocking answers, advancing treatments, and delivering hope to millions of families impacted by Alzheimer’s disease.
###